Cargando…

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

The contributions of the humoral immune response to melanoma are now widely recognized, with reports of positive prognostic value ascribed to tumor-infiltrating B cells (TIL-B) and increasing evidence of B cells as key predictors of patient response to treatment. There are disparate views as to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willsmore, Zena N., Harris, Robert J., Crescioli, Silvia, Hussein, Khuluud, Kakkassery, Helen, Thapa, Deepika, Cheung, Anthony, Chauhan, Jitesh, Bax, Heather J., Chenoweth, Alicia, Laddach, Roman, Osborn, Gabriel, McCraw, Alexa, Hoffmann, Ricarda M., Nakamura, Mano, Geh, Jenny L., MacKenzie-Ross, Alastair, Healy, Ciaran, Tsoka, Sophia, Spicer, James F., Papa, Sophie, Barber, Linda, Lacy, Katie E., Karagiannis, Sophia N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868381/ https://www.ncbi.nlm.nih.gov/pubmed/33569063 http://dx.doi.org/10.3389/fimmu.2020.622442

Ejemplares similares

Enriched circulating and tumor-resident TGF-β(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs
por: Harris, Robert J, et al.
Publicado: (2022)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
por: Crescioli, Silvia, et al.
Publicado: (2023)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

Generation and Characterization of Native and Sialic Acid-Deficient IgE
por: McCraw, Alex J., et al.
Publicado: (2022)

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
por: Pellizzari, Giulia, et al.
Publicado: (2019)

Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
por: Khair, Duaa O., et al.
Publicado: (2019)

BRAF inhibitors: resistance and the promise of combination treatments for melanoma
por: Griffin, Merope, et al.
Publicado: (2017)

Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients
por: Karagiannis, Panagiotis, et al.
Publicado: (2021)

Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade
por: Patel, Akshay J., et al.
Publicado: (2022)

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
por: Saul, Louise, et al.
Publicado: (2016)

Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
por: Nakamura, Mano, et al.
Publicado: (2019)

CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
por: Cheung, Anthony, et al.
Publicado: (2022)

Novel drug-target interactions via link prediction and network embedding
por: Amiri Souri, E., et al.
Publicado: (2022)

Drug repurposing and prediction of multiple interaction types via graph embedding
por: Amiri Souri, E., et al.
Publicado: (2023)

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
por: Bax, Heather J., et al.
Publicado: (2022)

Utilizing Immunocytokines for Cancer Therapy
por: Runbeck, Erin, et al.
Publicado: (2021)

Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
por: Harris, Robert J., et al.
Publicado: (2021)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer
por: Amiri Souri, E., et al.
Publicado: (2021)

Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
por: Gilbert, Amy E., et al.
Publicado: (2011)

Plication procedures—excisional and incisional corporoplasty and imbrication for Peyronie’s disease
por: Chen, Roger, et al.
Publicado: (2016)

Community-Acquired, Post-COVID-19, Methicillin-Resistant Staphylococcus aureus Pneumonia and Empyema
por: McCraw, Cameron, et al.
Publicado: (2022)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms
por: McCraw, Dustin M., et al.
Publicado: (2016)

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021)

Mechanisms of C. Parvum-induced coagulopathy in mice.
por: Mitcheson, H. D., et al.
Publicado: (1980)

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017)

UBC13-mediated template switching promotes replication stress resistance in FBH1-deficient cells
por: Hawks, Alexandra L., et al.
Publicado: (2023)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

Special Issue “Antibody Engineering for Cancer Immunotherapy”
por: Crescioli, Silvia, et al.
Publicado: (2022)

B Lymphocytes Accumulate and Proliferate in Human Skin at Sites of Cutaneous Antigen Challenge
por: Egbuniwe, Isioma U., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_np3b44e4nlmogqt4t81ll06ito